Association of HLA class I homozygosity with unfavorable clinical outcomes in patients with non-small cell lung cancer treated with chemo-immunotherapy or immunotherapy as first-line therapy.

Heliyon · 2021 · PMC8449023 · PMID 34568594

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

Due to limited sample size, our analysis failed to reach statistical significance.

also in 6,035 other papers

did not reach statistical significanceno p-value reported

There existed correlation between HLA-I homozygosity and shorter PFS, but it did not reach statistical significance in patients with advanced NSCLC.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.